Nursing Management of Cancer Treatment–Induced Cardiotoxicity

Available until 10/22/2026
1.0 contact hour available
Posted by i3Health on 6/10/2025

This activity will explore key insights into the nursing management of cancer treatment–induced cardiotoxicity.

Management of Cancer Pain: Current Guidelines

Available until 11/19/2025
1.0 contact hour available
Posted by i3Health on 6/10/2025

This activity will provide an overview of the pathophysiology of cancer pain and explore emerging concepts in pharmacological management to improve quality of life.

Nursing Management of Bone Health in Patients With Cancer

Available until 12/18/2026
1.0 contact hour available
Posted by i3Health on 6/10/2025

This activity will provide an update on nursing management of bone health in patients with cancer.

Nursing Management of Tumor Lysis Syndrome

Available until 2/3/2026
1.0 CME credit available (1.0 pharmacology)
Posted by i3Health on 6/10/2025

This activity will explore the nursing management of TLS, including the pathophysiology, identification of patients at risk and the appropriate prophylactic treatment

Acromegaly Update: Assessing Post-Surgical Response and Determining Next Steps

Available until 2/25/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This educational guide will explore consensus recommendations concerning post-surgical treatment and assessment of therapeutic response for patients with acromegaly.

ISTH’s Take on Hemophilia Prophylaxis: An Exploration of the Guidelines

Available until 2/5/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This monograph is designed to help hematologists, and other clinicians understand the recommendations in the recent ISTH Clinical Practice Guideline for the Treatment of Congenital Hemophilia A and B

Two Targets, One Mission: Advancing Cancer Care With Bispecific Antibodies

Available until 3/12/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

Despite compelling evidence supporting the efficacy of bispecific antibodies in relapsed/refractory cancers, clinical adoption is hindered by knowledge gaps in mitigating and managing toxicities.

Smart Bombs in Cancer Care: Unlocking the Potential of Antibody-Drug Conjugates

Available until 3/19/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This practical guide will help bridge some of these gaps by providing key insights into the complex landscape of ADCs, including their mechanisms of action, clinical applications, and limitations.

Biosimilars Explained: An Indispensable Tool for Modern Oncology Practice

Available until 3/26/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This monograph provides a comprehensive overview of biosimilars in oncology, addressing key barriers to adoption and offering practical guidance for their implementation in clinical practice.

Podcast: What’s New With HER2: Charting New Paths in NSCLC Care — Module 2

Available until 12/4/2025
0.25 CME credits available
Posted by i3Health on 6/4/2025

In module 2 of this podcast, expert faculty will explore actionable insights and testing recommendations for HER2 alterations in NSCLC.